NCT06013800

Brief Summary

This observational study aims to analyze the time of correction of hyponatremia in patients within an internal medicine ward. The researchers will assess volume status using both clinical evaluation and point-of-care ultrasound. Patients will be categorized based on whether they have the same volume status determined clinically and by ultrasound or a different status between the two methods. By tracking sodium levels daily until normalization, the study will compare the time of hyponatremia correction between the two groups.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 11, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 28, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

August 11, 2023

Last Update Submit

November 14, 2024

Conditions

Keywords

hyponatremiawater-electrolyte imbalancePOCUSPoint-of-care ultrasound

Outcome Measures

Primary Outcomes (1)

  • Rate of participants with sodium level >135mEq/L

    Rate of Achieving a Normal Sodium Level (\>135mEq/L) per Participant: This information will be visually represented through Group 1 and Group 2 using a Kaplan-Meier curve. Subsequently, the data will be evaluated using the Log-Rank test or the Breslow test for statistical significance.

    Baseline, everyday up to 30 days

Secondary Outcomes (1)

  • Assessment of clinical variables associated with corrected sodium levels

    Baseline, up to 30 days

Study Arms (2)

Same Volume Status (Clinical and Point-of-Care Ultrasound)

The patient has the same volume status clinically and by point-of-care ultrasound

Other: Measurement of sodium levels

Different Volume Status (Clinical or Point-of-Care Ultrasound)

The patient has a different volume status clinically or by point-of-care ultrasound

Other: Measurement of sodium levels

Interventions

Patients will get measurements of sodium levels daily in the first 48 hours, then daily or every other day until normal sodium levels (\>135mEq/L).

Different Volume Status (Clinical or Point-of-Care Ultrasound)Same Volume Status (Clinical and Point-of-Care Ultrasound)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with hypotonic hyponatremia

You may qualify if:

  • Age greater or equal to 18 years
  • Hypotonic hyponatremia (less than 275mosm/kg) calculated by the following formula (2 Na+Glucose/ 18)

You may not qualify if:

  • Patients who are critically ill with ventilatory support.
  • Patients with clinical signs suggestive of hypovolemia and have a documented history of aortic insufficiency or show mitral insufficiency during POCUS (Point-of-Care Ultrasound).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Regional B Veracruz Alta Especialidad

Veracruz, 91700, Mexico

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood

MeSH Terms

Conditions

HyponatremiaWater-Electrolyte Imbalance

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Alejandro Martínez Carreón, MD

    Universidad Veracruzana

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 11, 2023

First Posted

August 28, 2023

Study Start

October 1, 2023

Primary Completion

October 1, 2024

Study Completion

December 1, 2024

Last Updated

November 19, 2024

Record last verified: 2024-11

Locations